Dara files $30 million shelf registration

By Devika Patel

Knoxville, Tenn., April 9 - Dara BioSciences, Inc. filed a $30 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers preferred stock, common stock, debt securities and warrants.

The preferred stock and debt securities may be convertible.

Proceeds will be used for working capital and other general corporate purposes.

Based in Raleigh, N.C., Dara is a pharmaceutical company that acquires therapeutic molecules and medical technologies.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.